Bank of America Corp DE cut its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 52.7% during the second quarter, HoldingsChannel.com reports. The firm owned 31,105 shares of the company’s stock after selling 34,589 shares during the period. Bank of America Corp DE’s holdings in USANA Health Sciences were worth $2,471,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in USNA. Invesco Ltd. grew its holdings in shares of USANA Health Sciences by 208.9% in the 2nd quarter. Invesco Ltd. now owns 52,408 shares of the company’s stock worth $4,163,000 after purchasing an additional 35,443 shares during the last quarter. AMP Capital Investors Ltd bought a new stake in shares of USANA Health Sciences in the 2nd quarter worth about $442,000. Tower Research Capital LLC TRC bought a new stake in shares of USANA Health Sciences in the 2nd quarter worth about $27,000. BlackRock Inc. grew its holdings in shares of USANA Health Sciences by 72.6% in the 2nd quarter. BlackRock Inc. now owns 2,302,511 shares of the company’s stock worth $182,889,000 after purchasing an additional 968,239 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of USANA Health Sciences by 4.2% in the 2nd quarter. Northern Trust Corp now owns 198,575 shares of the company’s stock worth $15,773,000 after purchasing an additional 8,032 shares during the last quarter. 63.43% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have recently weighed in on the stock. ValuEngine raised shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, August 1st. Pivotal Research reaffirmed a “buy” rating on shares of USANA Health Sciences in a report on Wednesday, July 24th. Sidoti lowered shares of USANA Health Sciences from a “buy” rating to a “neutral” rating and set a $70.00 target price on the stock. in a report on Wednesday, July 3rd. Jefferies Financial Group assumed coverage on shares of USANA Health Sciences in a report on Thursday, August 22nd. They issued a “hold” rating and a $65.00 target price on the stock. Finally, TheStreet lowered shares of USANA Health Sciences from a “b-” rating to a “c+” rating in a report on Thursday, July 11th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $70.00.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $0.91 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.93 by ($0.02). The company had revenue of $256.00 million for the quarter, compared to analyst estimates of $254.66 million. USANA Health Sciences had a return on equity of 27.22% and a net margin of 9.68%. The firm’s quarterly revenue was down 15.1% on a year-over-year basis. During the same quarter last year, the company earned $1.36 EPS. On average, research analysts predict that USANA Health Sciences, Inc. will post 3.78 earnings per share for the current year.
In related news, Director Robert Auciaux sold 4,018 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $71.87, for a total transaction of $288,773.66. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 42.50% of the stock is owned by corporate insiders.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Read More: Initial Coin Offering (ICO)
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.